entertainment -WSS

entertainment

author：explore 2025-09-27 12:58:25 - browse：32558

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： How to bring more disabled researchers into academia

hotspot

WSS

The Affordable Care Act has saved billions in health care costs

Pancreatic cancer early detection could be helped by AI

Medicare drug price negotiation legal challenge met with skepticism

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

New clues to why women have higher risk of autoimmune disorders

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

focus

entertainment

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

Amylyx ALS drug failure raises questions and concerns

Affirmative action in medical school literally saved lives

Sen. Paul opposes bill to ban Chinese biotechs

As demand for Covid shots wanes, Moderna seeks its next success

IVF, abortion rights issues kick off Biden’s State of the Union

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

The cancer drug shortage isn’t new — and neither are the solutions

Syphilis numbers in the United States reach record heights

focus

Syphilis numbers in the United States reach record heights

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

UnitedHealth quietly bought dozens of outpatient centers

Vertex non

How generative AI ratchets up security threats for health systems

Why you shouldn’t ask, “What country has the best health care?”

hotspot

hotspot

explore

explore